We are committed to finding a cure for WM.

Toronto Lending Library

Catalogue of Contents

Download the Catalogue in PDF

Updated September 24, 2015

CDs

Copies:

5     “The First Step to Cancer Survival – Cancer Survival Toolbox” (NCCS-National   Coalition for Cancer Survivorship, 2009) – booklet & 10 audio CDs

 

DVDs 

Copies:

5      IWMF Educational Forum Presentations (4 selections for newly diagnosed)

May 18-19, 2013 – 18th Annual (San Diego, California)

Drs. Robert Kyle, Joseph Mikhail and Morie Gertz

 

PAMPHLETS

Copies:

1    “Medical Tests” (IWMF, March 2007)

5    “Basic Immunology in WM” (IWMF, 2007-3 copies, reprint 2011-1 copy, Revised 2014-1 copy)

1    “Healthy Living” (IWMF, March 2007)

1    “Questions and Answers” (IWMF, January 2010)

3    “Treatment Options” (IWMF, March 2013)

1    “Review of Therapy” (IWMF, 2013 / 2014 updated by Morie Gertz, M.D.)

1    “Eat Well, Be Active” (Canadian Cancer Society)

7    “Blood Tests”   (IWMF, October 2012)

1    “Blood: How I Treat Waldenstrom Macroglobulinemia” (Steven P. Treon, Journal of the American Society of Hematology, Vol.114, Number 12, September 17,     2009)

 

BOOKLETS

Copies:

5   “Understanding Drug Therapy and Managing Side Effects” (The Leukemia and Lymphoma Society, January 2010)

3   “Blood and Marrow Stem Cell Transplantation” (The Leukemia and Lymphoma Society, July 2010)

3    “Understanding Clinical Trials for Blood Cancers” (The Leukemia and Lymphoma Society, June 2006)

3    “Knowing All your Treatment Options” (The Leukemia and Lymphoma Society,  October, 2010)

5    “Blood Transfusion” (The Leukemia and Lymphoma Society, Blood Cancer Treatment Series, 2011)

1    “Charitable Giving in Canada” (Preet Banerjee)  www.ExecutiveFinancialPlanning.com

7   “Comprehensive Glossary for Patients with WM” (IWMF March 2011)

1   “Cancer in Older Adults”   (American Society of Clinical Oncology, 2010)

5   “Each New Day” Ideas for Coping with Blood Cancers (The Leukemia and Lymphoma Society, December, 2008)

1   “Waldenstrom Macroglobulinemia Facts” (The Leukemia and Lymphoma Society, January, 2012)

9   “Caring for the Caregiver” (National Cancer Institute, National Institutes of  Health, June 2007)

2   “Torch” (IWMF Newsletter, January 2015)

 

SOFT COVER BOOKS

Copies:

 

1     “Cancer Smart 3.0 The Consumer Guide”

1   “Clinical Lymphoma & Myeloma, Special Issue on WM” (5th International   Workshop on WM, Stockholm, Sweden, Oct. 15-19, 2008)

2  “Clinical Lymphoma, Special Issue on WM” (3rd International Workshop on WM, Paris, France, October 7-10, 2004)

1   “How the Immune System Works” (Lauren Sompayrac ©1999)

1   “The Healing Circle – Integrating science, wisdom and compassion in reclaiming wholeness on the cancer journey” (Dr. Rob Rutledge, MD and Timothy  Walker, PhD. © 2010, The Healing and Cancer Foundation)

1    “Twelve Weeks – An Artist’s Story of Cancer, Healing and Hope” (Karen Lee Sobol © 2010)

1     “Cancer is a Word, not a Sentence” (Dr. Robert Buckman © 2007)

1    “Never Be Sick Again” (Raymond Francis, M.Sc. with Kester Cotton,  © 2002)

2   “The Chemo Zone –Your Concise Guide to Living and Flourishing During   Chemotherapy” (Linda Rubietta with Tracy Rubietta ©2013)

 

 

MAGAZINES

1   “Cure – Cancer Resource Guide” (Cure media group, with American Cancer  Society, 2011 edition)

2   “Cure – Cancer Updates, Research & Education” (Cure media group,  spring issue 2011)

 

WELLSPRING

Many articles providing information about the programs and services offered by Wellspring, A Lifeline to Cancer Support, at its 4 nearby locations.

 

 

INFORMATION SHEETS

Copies of these information sheets are available for anyone to take and keep.

 

“Waldenstrom Macroglobulinemia”   (The Leukemia & Lymphoma Society)

“Waldenstom’s Macroglobulinemia Small Disease with Big Consequences”  (Mayo Clinic)

“Blood”

“Cholesterol”

“Transplants of Hematopoietic Stem Cells”

“Serum Beta-2 Microglobulins Explanation”   (IWMF)

“Glossary of WM Related Terms”   (IWMF)

“Peripheral Neuropathies in WM”   (J Neural Neurosurg. Psychiatry, 2006)

“Final Progress Report” on BLyS inhibition in immunoglobulin producing B-cells   (Dr. Stephen Ansell, Mayo Clinic, 2006)

“Nourishing Hope When Illness Seems Hopeless” (Jane Brody)

“2007 IWMF Educational Forum Journal Articles” (list)

“Clonotypic IgM V/D/J sequence analysis in WM suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood” (S. Treon, L. Pilarski and others, 2004)

“Impaired class switch recombination (CSR) in WM despite apparently normal CSR machinery”   (L. Pilarski and others, 2006)

“Nonfluent Aphasia in a Patient with WM” (J Clin Neurosci. 2007)

“Waldenstrom’s Macroglobulinemia” (reprinted from Mayo Clinic website)

“Why Should I Participate in a Clinical Trial?” (Dr. Morie Gertz and others, Mayo Clinic)

“Experimental Vaccine Promises Relief from Shingles”

“What is the Role of Maintenance Rituximab in Follicular NHL?”(Oncology, 2008)

MedMaster Patient Drug Information on the following drugs:

  •             Bortezomib
  •             Chlorambucil
  •             Cyclophosphamide
  •             Thalidomide
  •             Prednisone
  •             Fludarabine Phosphate
  •             Rituximab Injection
  •             Vincristine

“Stemming the Tumorous Tide” (Economist.com, 2008) – e-mail and article

“Facts on Diffuse Large B-Cell Lymphoma” (Lymphoma Research Foundation)

“WM: clinical features, complications, and management” (University of Athens,   Greece, 2000)

“Undergoing Treatment” (IWMF Treatment Primer, 2010)

Newsletter, September 2010 – includes “Clinical Trials – Take II” (Bing     Centre for Waldenstrom’s Macroglobulinemia)

“Transplants of Hematopoietic Stem Cells”

“Rituxan / Rituximab, Highlights of Prescribing Information and Medication Guide” (Biogen Idec Inc. & Genentech Inc., 2011)

“Blood – Functions and Formation” (Biology Pages / B / Blood. html, 2010)

“Rituxan / Rituximab” (general info)

“Medication Guide – Rituxan” (revised 10 / 2010)

“The Rituximab and IVIG related IGM flare in WM” (S. Treon and others)

“Maintenance Rituximab is associated with improved clinical outcome…………”    (S. Treon and others)

“Clinical characteristics and treatment outcome of disease related peripheral           neuropathy in WM” (S. Treon and others)

“The attainment of CR / VGPR is associated with significantly longer progression             free survival………..” (S. Treon and others)

“The anti-CD20 monoclonal antibody GA101 displays more robust anti-tumor       activity versus Rituximab in WM” (S. Treon and others)

“Immune System Trained to Kill Cancer”

“Evolving Concepts in the Treatment of WM” (Dr. S. Treon, Physician Perspective, Considerations in Lymphoma, November 2011)

“Pharmacist Considerations in the Treatment of WM” (Caroline Harvey, MS,  RPh., Pharmacist Perspective, Considerations in Lymphoma,  November 2011

“Improving Patient Outcomes in WM” (Patricia Sheehy, ANP-BC, OCN, Nurse Perspective, Considerations in Lymphoma, November 2011)

“Choosing a Blood Cancer Specialist or Treatment Centre” (The Leukemia & Lymphoma Society)

“Integrative Medicine & Complementary and Alternative Therapies as Part of Blood Cancer Care” (The Leukemia & Lymphoma Society)

“MYD88 L265P Somatic Mutation in WM” (Abstract – Dr. S. Treon et al, 2012)

“Treatment Regimes used in Ontario for WM, and how they are paid for” (compiled by David Johnston, 2013)

“Scientists find a Master Control Gene for Blood Stem Cells”(newspaper article, 2013 ?)

“Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration” (February 12, 2013) + copy of Press Release for Waldenstrom`s

“Medical Questionnaire and Tissue Banking for Multiple Myeloma, WM and Related Disorders” (Dr. Irene Ghobrial, Dana-Farber Cancer Institute)

Treon Lecture “Meet the Professor”, Lugano Switzerland, 2013 (web link from Christopher Patterson, October 2, 2013)

“German Study Finds Bendamustine Improves Progression-free Survival in  Patients with Non-Hodgkin Lymphoma”(Caroline Helwick, The ASCO  Post, July 1, 2012)

“Bendamustine plus Rituximab versus CHOP plus Rituximab as first-line   treatment for patients with indolent and mantle-cell lymphomas: an open-  label, multicentre, randomized, phase 3 non-inferiority trial” (Abstract,the Lancet, April 6, 2013)

“Ibrutinib Fact Sheet” (Adapted from the Chemocare website,  www.chemocare.com, sponsored by the Cleveland Clinic)

“Bendamustine Fact Sheet” (Adapted from the Chemocare website,  www.chemocare.com, sponsored by the Cleveland Clinic)

“Velcade Fact Sheet” (Adapted from the Chemocare website, www.chemocare.com, sponsored by the Cleveland Clinic)

“Rituxan Fact Sheet” (Adapted from the Chemocare website, www.chemocare.com, sponsored by the Cleveland Clinic)

“Plasmapheresis Fact Sheet” (through IWMF)

“Stem Cell Transplantation/Stem Cell Banking Fact Sheet” (through IWMF)

“Newly Diagnosed Ed Forum Breakout” (IWMF)

“The Immune Response to WM: Implications for Immunotherapy”,  Principal Investigator: Brad Nelson, PhD, Trev and Joyce Deeley   Research Center, Victoria, BC, Canada (IWMF article)

“Information about PROCRIT (Epoetin alfa) for chemo-related anemia in patients  with most types of cancer” (Strength 4 Your Journey)